# Commission Implementing Decision (EU) 2018/1143 of 10 August 2018 amending Decisions 92/260/EEC and 93/197/EEC as regards the testing for equine viral arteritis (notified under document C(2018) 5071) (Text with EEA relevance), Annex II

Extent: E+W+S+N.I.

Decision 93/197/EEC is amended as follows:
(1) in each of the health certificates in Annex II (A), (C), (D) and (E), point (e)(v) of Section III is replaced by the following:
‘(3) (v)
in the case of an uncastrated male animal older than 180 days,
either equine viral arteritis has not been officially recorded during the last 6 months (3);
or
the animal was tested on a blood sample taken within 21 days prior to export on … (4) by virus neutralisation test for equine viral arteritis with negative result at a serum dilution of 1 in 4 (3);
or
an aliquot of its entire semen taken within 21 days prior to export on … (4) was tested by virus isolation test for equine viral arteritis with negative result (3);
or
the animal was subjected to a virus isolation test, polymerase chain reaction (PCR) or real-time PCR for equine viral arteritis carried out with negative result on an aliquot of its entire semen collected after the date a blood sample of that animal taken on … (4), within a period of 6 months prior to the date of dispatch, was tested in a virus neutralisation test for equine viral arteritis with positive result at a serum dilution of at least 1 in 4 (3);
or
within a period of 6 months prior to the date of dispatch, the male equine animal, previously tested positive for antibodies against the equine arteritis virus or vaccinated against equine viral arteritis, was:
(a) test mated, on two consecutive days, to at least two mares kept in isolation during the 7 days prior to and until at least 28 days after test mating, which were subjected to two serological tests for equine viral arteritis with negative results at a serum dilution of 1 in 4 on blood samples collected at the time of test mating and at least 28 days after the test mating; and
(b) subjected to a virus neutralisation test for equine viral arteritis carried out on a blood sample taken within 21 days prior to the date of dispatch on … (4):
either with positive result at a serum dilution of at least 1 in 4 (3), or
with negative result at a serum dilution of 1 in 4 (3);
or
the animal was vaccinated on … (4) against equine viral arteritis under official veterinary supervision with a vaccine approved by the competent authority, according to the following programmes for initial vaccination and has been revaccinated at regular intervals (3):
Programmes for initial vaccination against equine viral arteritis:
Instruction Cross out vaccination programmes that do not apply to the animal described above.
Verify supporting certification on testing before vaccination, on vaccination and re-vaccination.
(a) Vaccination was carried out on the day a blood sample was taken that subsequently proved negative in a virus neutralisation test at a serum dilution of 1 in 4 (3); or
(b) Vaccination was carried out during a period of isolation of not more than 15 days under official veterinary supervision, commencing on the day a blood sample was taken that was tested during that time with negative result in a virus neutralisation test at a serum dilution of 1 in 4 (3); or
(c) Vaccination was carried out when the animal was at an age of 180 to 270 days, during a period of isolation under official veterinary supervision. During the isolation period two blood samples taken at least 10 days apart proved a stable or declining antibody titre in a virus neutralisation test for equine viral arteritis (3); or
(d) Vaccination was carried out after the animal was subjected to a virus neutralisation test for equine viral arteritis with negative result at a serum dilution of 1 in 4, carried out on a blood sample taken not earlier than 7 days after commencing a period of uninterrupted isolation which lasted until 21 days following vaccination (3); or
(e) Vaccination was carried out at the age of 180 to 250 days, after the animal was subjected to a virus neutralisation test for equine viral arteritis carried out with negative result at a serum dilution of 1 in 4, or carried out on the same day by the same laboratory with stable or declining titres on two blood samples taken at least 14 days apart (3);’;
(2) in the health certificate in Annex II (B), point (e)(v) of Section III is replaced by the following:
‘(2) (v)
in the case of an uncastrated male animal older than 180 days,
either equine viral arteritis has not been officially recorded during the last 6 months (2);
or
the animal was tested on a blood sample taken within 21 days prior to export on … (4) by virus neutralisation test for equine viral arteritis with negative result at a serum dilution of 1 in 4 (2);
or
an aliquot of its entire semen taken within 21 days prior to export on … (4) was tested by virus isolation test for equine viral arteritis with negative result (2);
or
the animal was subjected to a virus isolation test, polymerase chain reaction (PCR) or real-time PCR for equine viral arteritis carried out with negative result on an aliquot of its entire semen collected after the date a blood sample of that animal taken on … (4), within a period of 6 months prior to the date of dispatch, was tested in a virus neutralisation test for equine viral arteritis with positive result at a serum dilution of at least 1 in 4 (2);
or
within a period of 6 months prior to the date of dispatch, the male equine animal, previously tested positive for antibodies against the equine arteritis virus or vaccinated against equine viral arteritis, was:
(a) test mated, on two consecutive days, to at least two mares kept in isolation during the 7 days prior to and until at least 28 days after test mating, which were subjected to two serological tests for equine viral arteritis with negative results at a serum dilution of 1 in 4 on blood samples collected at the time of test mating and at least 28 days after the test mating; and
(b) subjected to a virus neutralisation test for equine viral arteritis carried out on a blood sample taken within 21 days prior to the date of dispatch on … (4):
either with positive result at a serum dilution of at least 1 in 4 (2), or
with negative result at a serum dilution of 1 in 4 (2);
or
the animal was vaccinated on … (4) against equine viral arteritis under official veterinary supervision with a vaccine approved by the competent authority, according to the following programmes for initial vaccination and has been revaccinated at regular intervals (2):
Programmes for initial vaccination against equine viral arteritis:
Instruction Cross out vaccination programmes that do not apply to the animal described above.
Verify supporting certification on testing before vaccination, on vaccination and re-vaccination.
(a) Vaccination was carried out on the day a blood sample was taken that subsequently proved negative in a virus neutralisation test at a serum dilution of 1 in 4 (2); or
(b) Vaccination was carried out during a period of isolation of not more than 15 days under official veterinary supervision, commencing on the day a blood sample was taken that was tested during that time with negative result in a virus neutralisation test at a serum dilution of 1 in 4 (2); or
(c) Vaccination was carried out when the animal was at an age of 180 to 270 days, during a period of isolation under official veterinary supervision. During the isolation period two blood samples taken at least 10 days apart proved a stable or declining antibody titre in a virus neutralisation test for equine viral arteritis (2); or
(d) Vaccination was carried out after the animal was subjected to a virus neutralisation test for equine viral arteritis with negative result at a serum dilution of 1 in 4, carried out on a blood sample taken not earlier than 7 days after commencing a period of uninterrupted isolation which lasted until 21 days following vaccination (2); or
(e) Vaccination was carried out at the age of 180 to 250 days, after the animal was subjected to a virus neutralisation test for equine viral arteritis carried out with negative result at a serum dilution of 1 in 4, or carried out on the same day by the same laboratory with stable or declining titres on two blood samples taken at least 14 days apart (2);’.

---
Source: https://www.legislation.gov.uk/eudn/2018/1143/annex/II (the official version)
Page: https://openlegislation.uk/eu-decision-2018-1143/annex-II
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.